Hospice Touch in Tomah, Wisconsin

Hospice Touch is a medicare-certified hospice facility in Tomah, Wisconsin. It is a non-profit hospice and this hospice is a Freestanding Hospice. It is located at 601 Straw St in Tomah, Wisconsin. You can reach out to the office of Hospice Touch via phone at (608) 374-0250.

Hospice Touch is first approved in June, 1993 to provide medicare and/or medicaid services and its CMS certification number (CCN) is 521547. Chicago is the CMS Regional Office responsible for the certification of this hospice.

Contact Information


Hospice Touch
601 Straw St, Tomah, WI, 54660
(608) 374-0250

News Archive

Short-term economic boom not always good for children in developing nations

A short-term economic boom is not always a good thing for children in developing nations, according to a new study in the Journal of Political Economy. The study found that when Colombia's coffee trade suddenly booms, illness and mortality rates among children increase in coffee-producing counties.

Leica Microsystems launches new neurosurgical microscope

Leica Microsystems has launched a new neurosurgical microscope, the Leica M530 OH6. To enable surgeons to see better into deep, narrow cavities, it is equipped with FusionOptics technology, advanced Small Angle Illumination (SAI) and apochromatic optics. The ergonomic design of the microscope enables surgeons and assistants to work in a neutral, upright posture which helps prevent strain and fatigue.

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.

Homologous recombination technology for research applications in genetically modified rodents: an interview with Alexandre Fraichard, CEO, genOway

Homologous recombination is a technology that enables the targeted insertion of nucleotide fragments into the genome of a cell. It is called ‘homologous' because it uses a sequence that is a homologue to the sequence being targeted in a gene, so that the sequence is recognized.

Researchers develop a nanoparticle-based formulation with anti-SARS-CoV-2 activity

A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection blocking the interaction between viral spike protein and host cell angiotensin-converting enzyme 2 (ACE2).

Read more Medical News

› Verified 1 days ago

Map and Direction



Hospice Profile

NameHospice Touch
Location601 Straw St, Tomah, Wisconsin
Hospice ID521547
CategoryFreestanding Hospice
Ownership TypeVoluntary Non-profit - Other
Profit TypeNON-PROFIT
Accreditation ProviderThe Joint Commission (TJC)
SSA county code400

News Archive

Short-term economic boom not always good for children in developing nations

A short-term economic boom is not always a good thing for children in developing nations, according to a new study in the Journal of Political Economy. The study found that when Colombia's coffee trade suddenly booms, illness and mortality rates among children increase in coffee-producing counties.

Leica Microsystems launches new neurosurgical microscope

Leica Microsystems has launched a new neurosurgical microscope, the Leica M530 OH6. To enable surgeons to see better into deep, narrow cavities, it is equipped with FusionOptics technology, advanced Small Angle Illumination (SAI) and apochromatic optics. The ergonomic design of the microscope enables surgeons and assistants to work in a neutral, upright posture which helps prevent strain and fatigue.

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.

Homologous recombination technology for research applications in genetically modified rodents: an interview with Alexandre Fraichard, CEO, genOway

Homologous recombination is a technology that enables the targeted insertion of nucleotide fragments into the genome of a cell. It is called ‘homologous' because it uses a sequence that is a homologue to the sequence being targeted in a gene, so that the sequence is recognized.

Researchers develop a nanoparticle-based formulation with anti-SARS-CoV-2 activity

A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection blocking the interaction between viral spike protein and host cell angiotensin-converting enzyme 2 (ACE2).

Read more Medical News

› Verified 1 days ago

NPI associated with this Hospice

A hospice usually have one NPI number but sometimes it may have multiple NPI numbers. We have found possible NPI number/s associated with Hospice Touch from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1588706329
Organization NameTomah Memorial Hospital Inc
Address300 Butts Ave Tomah, Wisconsin, 54660
Phone Number(608)372-2181

News Archive

Short-term economic boom not always good for children in developing nations

A short-term economic boom is not always a good thing for children in developing nations, according to a new study in the Journal of Political Economy. The study found that when Colombia's coffee trade suddenly booms, illness and mortality rates among children increase in coffee-producing counties.

Leica Microsystems launches new neurosurgical microscope

Leica Microsystems has launched a new neurosurgical microscope, the Leica M530 OH6. To enable surgeons to see better into deep, narrow cavities, it is equipped with FusionOptics technology, advanced Small Angle Illumination (SAI) and apochromatic optics. The ergonomic design of the microscope enables surgeons and assistants to work in a neutral, upright posture which helps prevent strain and fatigue.

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.

Homologous recombination technology for research applications in genetically modified rodents: an interview with Alexandre Fraichard, CEO, genOway

Homologous recombination is a technology that enables the targeted insertion of nucleotide fragments into the genome of a cell. It is called ‘homologous' because it uses a sequence that is a homologue to the sequence being targeted in a gene, so that the sequence is recognized.

Researchers develop a nanoparticle-based formulation with anti-SARS-CoV-2 activity

A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection blocking the interaction between viral spike protein and host cell angiotensin-converting enzyme 2 (ACE2).

Read more Medical News

› Verified 1 days ago


Quality of Patient Care at Hospice Touch

Hospice staff should discuss treatment preferences and patient beliefs and values with patients and/or caregivers. They should also identify and provide interventions to address pain, shortness of breath and constipation (caused by opioids) to improve patient comfort and quality of life. Hospice Touch has the following score in these measures of patient care.
Better than National Average Worse than National Average

Quality MeasureProvider ScoreNational Score
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care100.098.3
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care99.493.6
Patients who were checked for pain at the beginning of hospice care100.093.9
Patients who got a timely and thorough pain assessment when pain was identified as a problem75.077.7
Patients who were checked for shortness of breath at the beginning of hospice care100.097.3
Patients who got timely treatment for shortness of breath95.694.6
Patients taking opioid pain medication who were offered care for constipation90.093.3

News Archive

Short-term economic boom not always good for children in developing nations

A short-term economic boom is not always a good thing for children in developing nations, according to a new study in the Journal of Political Economy. The study found that when Colombia's coffee trade suddenly booms, illness and mortality rates among children increase in coffee-producing counties.

Leica Microsystems launches new neurosurgical microscope

Leica Microsystems has launched a new neurosurgical microscope, the Leica M530 OH6. To enable surgeons to see better into deep, narrow cavities, it is equipped with FusionOptics technology, advanced Small Angle Illumination (SAI) and apochromatic optics. The ergonomic design of the microscope enables surgeons and assistants to work in a neutral, upright posture which helps prevent strain and fatigue.

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.

Homologous recombination technology for research applications in genetically modified rodents: an interview with Alexandre Fraichard, CEO, genOway

Homologous recombination is a technology that enables the targeted insertion of nucleotide fragments into the genome of a cell. It is called ‘homologous' because it uses a sequence that is a homologue to the sequence being targeted in a gene, so that the sequence is recognized.

Researchers develop a nanoparticle-based formulation with anti-SARS-CoV-2 activity

A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection blocking the interaction between viral spike protein and host cell angiotensin-converting enzyme 2 (ACE2).

Read more Medical News

› Verified 1 days ago


Services Provided by Hospice Touch:

Hospice provide various services either through their own staff or through third-party arrangements. Find the list of services provided by Hospice Touch below:
  • By staff
    • Counseling Service
    • Medical Social Service
    • Medical Supply Service
    • Nursing Service
    • Occupational Therapy
    • Physician Service
    • Physical Therapy
    • Short Term Inpatient care

  • Under Arrangement
    • Speech Pathology

  • Combination of Staff and Under Arrangement
    • Home Health Aide Service

  • Type of Short Term Inpatient Care
    • Acute and Respite

Number of Full-time equivalent Employees:

Number of full time equivalent employees at Hospice Touch
Home Health Aides2.5
Counselors0.5
Medical Social Workers 1
Registered Nurses3.75
Total Employees7.75

News Archive

Short-term economic boom not always good for children in developing nations

A short-term economic boom is not always a good thing for children in developing nations, according to a new study in the Journal of Political Economy. The study found that when Colombia's coffee trade suddenly booms, illness and mortality rates among children increase in coffee-producing counties.

Leica Microsystems launches new neurosurgical microscope

Leica Microsystems has launched a new neurosurgical microscope, the Leica M530 OH6. To enable surgeons to see better into deep, narrow cavities, it is equipped with FusionOptics technology, advanced Small Angle Illumination (SAI) and apochromatic optics. The ergonomic design of the microscope enables surgeons and assistants to work in a neutral, upright posture which helps prevent strain and fatigue.

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.

Homologous recombination technology for research applications in genetically modified rodents: an interview with Alexandre Fraichard, CEO, genOway

Homologous recombination is a technology that enables the targeted insertion of nucleotide fragments into the genome of a cell. It is called ‘homologous' because it uses a sequence that is a homologue to the sequence being targeted in a gene, so that the sequence is recognized.

Researchers develop a nanoparticle-based formulation with anti-SARS-CoV-2 activity

A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection blocking the interaction between viral spike protein and host cell angiotensin-converting enzyme 2 (ACE2).

Read more Medical News

› Verified 1 days ago


Number of Full-time equivalent Volunteers:

Physicians0.25
Total Volunteers0.25

News Archive

Short-term economic boom not always good for children in developing nations

A short-term economic boom is not always a good thing for children in developing nations, according to a new study in the Journal of Political Economy. The study found that when Colombia's coffee trade suddenly booms, illness and mortality rates among children increase in coffee-producing counties.

Leica Microsystems launches new neurosurgical microscope

Leica Microsystems has launched a new neurosurgical microscope, the Leica M530 OH6. To enable surgeons to see better into deep, narrow cavities, it is equipped with FusionOptics technology, advanced Small Angle Illumination (SAI) and apochromatic optics. The ergonomic design of the microscope enables surgeons and assistants to work in a neutral, upright posture which helps prevent strain and fatigue.

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.

Homologous recombination technology for research applications in genetically modified rodents: an interview with Alexandre Fraichard, CEO, genOway

Homologous recombination is a technology that enables the targeted insertion of nucleotide fragments into the genome of a cell. It is called ‘homologous' because it uses a sequence that is a homologue to the sequence being targeted in a gene, so that the sequence is recognized.

Researchers develop a nanoparticle-based formulation with anti-SARS-CoV-2 activity

A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection blocking the interaction between viral spike protein and host cell angiotensin-converting enzyme 2 (ACE2).

Read more Medical News

› Verified 1 days ago

Certification Details for Hospice Touch:

  • December, 1997 is the initial visit of the health survey for certifications by CMS.
  • It is in compliance at the time of certification survey by CMS.
  • It is in compliance with CMS program requirements based on an acceptable plan for correction of deficiencies.
  • It is eligible to participate in the medicare and/or medicaid program.
  • National Government Services is the Medicare Administrative Contractor (MAC), intermediary or carrier servicing this hospice.
  • Number assigned to the hospice by the state Medicaid agency for external control or billing purposes is 1588706329.
  • Current status is Active Provider.
  • Reason of certification is Recertification.
  • End of fiscal year is on 30, September.

Hospices in Tomah

Hospice Touch
Location: 601 Straw St, Tomah, Wisconsin, 54660
Phone: (608) 374-0250

Medicare Hospice Care

What is Hospice Care?
Hospice care is a type of care and philosophy of care that focuses on the palliation of a chronically ill, terminally ill or seriously ill patient's pain and symptoms, and attending to their emotional and spiritual needs. Care may be provided in a patient's home or in a designated facility such as nursing home, hospital unit or freestanding hospice, with level of care and sometimes location based upon frequent evaluation of the paients needs. The four primary levels of care provided by hospice are routine home care, continuous care, general inpatient and respite care.

How long can one get medicare hospice care?
Hospice care is for people with a life expectancy of 6 months or less (if the disease runs its normal course). If the person receiving hospice care live longer than 6 months, he or she can still get hospice care.
  • A person can get hospice care for two 90-day benefit periods, followed by an unlimited number of 60-day benefit periods.
  • At the start of each period, the hospice medical director or other hospice doctor must recertify that the person is terminally ill (with a life expectancy of 6 months or less). This step is must for continued hospice care.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.